Denali Therapeutics Stock Pattern Recognition Upside Gap Two Crows

DNLI Stock  USD 24.22  0.20  0.82%   
Denali Therapeutics pattern recognition tool provides the execution environment for running the Upside Gap Two Crows recognition and other technical functions against Denali Therapeutics. Denali Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Upside Gap Two Crows recognition function is designed to identify and follow existing trends. Denali Therapeutics momentum indicators are usually used to generate trading rules based on assumptions that Denali Therapeutics trends in prices tend to continue for long periods.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Upside Gap Two Crows pattern suggests that Denali Therapeutics investor sentiment is turning from bullish to bearish.

Denali Therapeutics Technical Analysis Modules

Most technical analysis of Denali Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Denali from various momentum indicators to cycle indicators. When you analyze Denali charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Denali Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Denali Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Denali Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Denali Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Denali Therapeutics's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Denali Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Denali Therapeutics, we also check how macroeconomic factors affect Denali Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 (projected)
Graham Number22.0313.3612.69
Receivables Turnover11.6996.65101.48
Hype
Prediction
LowEstimatedHigh
20.7824.2327.68
Details
Intrinsic
Valuation
LowRealHigh
21.8031.6835.13
Details
Naive
Forecast
LowNextHigh
16.0619.5122.97
Details
17 Analysts
Consensus
LowTargetHigh
50.6055.6061.72
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Cash Cows Idea
Cash Cows
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Power Assets Idea
Power Assets
Invested over 200 shares
FinTech Idea
FinTech
Invested over 40 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Military Industrial Idea
Military Industrial
Sold few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Momentum Idea
Momentum
Invested over 40 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
When determining whether Denali Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Denali Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Denali Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Denali Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Denali Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more detail on how to invest in Denali Stock please use our How to Invest in Denali Therapeutics guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Denali Therapeutics. If investors know Denali will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Denali Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.77)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.24)
Return On Equity
(0.35)
The market value of Denali Therapeutics is measured differently than its book value, which is the value of Denali that is recorded on the company's balance sheet. Investors also form their own opinion of Denali Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Denali Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Denali Therapeutics' market value can be influenced by many factors that don't directly affect Denali Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Denali Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Denali Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Denali Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.